Allan J. Walkey MD, MSc

Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine

Associate Professor, Health Law, Policy & Management

72 E. Concord Street | (617) 638-4860
Allan Walkey
Sections

Pulmonary, Allergy, Sleep & Critical Care Medicine

Centers

Evans Center for Implementation & Improvement Sciences

Pulmonary Center

Framingham Heart Study

Evans Center for Interdisciplinary Biomedical Research

Biography

Dr. Walkey investigates epidemiology and clinical outcomes of complications that occur in patients who are critically ill. Using clinical and administrative data, Dr. Walkey focuses on interations between organ systems during critical illness and seeks to find effective health care provider practice patterns that are associated with better patient outcomes. His research interests include sepsis, acute lung injury, and atrial fibrillation that occurs during critical illness.

Education

Medicine, MD, University of Massachusetts Medical School

Epidemiology, MS, Boston University School of Public Health

Psychology, BA, Tufts University

Publications

Published on 7/5/2024

Lee MM, Zuo Y, Steiling K, Mizgerd JP, Kalesan B, Walkey AJ. Clinical risk factors and blood protein biomarkers of 10-year pneumonia risk. PLoS One. 2024; 19(7):e0296139. PMID: 38968193.

Published on 6/19/2024

Cohen RT, Burrowes SAB, Williams CJ, Neri CM, Klings ES, Jones KC, Walkey AJ, Drainoni ML. SNAP: Supportive non-invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team. Pediatr Blood Cancer. 2024 Jun 19; e31142. PMID: 38896013.

Published on 6/3/2024

Myers LC, Soltesz L, Bosch N, Daly KA, Devis Y, Rucci J, Stevens J, Wunsch H, Jafarzadeh SR, Campbell CI, Liu VX, Walkey AJ. Intravenous Opioid Administration During Mechanical Ventilation and Use After Hospital Discharge. JAMA Netw Open. 2024 Jun 03; 7(6):e2417292. PMID: 38874921.

Published on 6/1/2024

Kearney CM, Sangani R, Shankar D, O'Connor GT, Law AC, Walkey AJ, Bosch NA. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis. Ann Am Thorac Soc. 2024 Jun; 21(6):866-874. PMID: 38241013.

Published on 5/21/2024

Silver SR, Jones KC, Hook K, Crable EL, George ER, Serwint JR, Austad K, Walkey A, Drainoni ML. Defining the transition from new to normal: a qualitative investigation of the clinical change process. Res Sq. 2024 May 21. PMID: 38826210.

Published on 5/15/2024

Teja B, Berube M, Pereira TV, Law AC, Schanock C, Pang B, Wunsch H, Walkey AJ, Bosch NA. Effectiveness of Fludrocortisone Plus Hydrocortisone versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Am J Respir Crit Care Med. 2024 May 15; 209(10):1219-1228. PMID: 38271488.

Published on 5/1/2024

Teja B, Bosch NA, Diep C, Pereira TV, Mauricio P, Sklar MC, Sankar A, Wijeysundera HC, Saskin R, Walkey A, Wijeysundera DN, Wunsch H. Complication Rates of Central Venous Catheters: A Systematic Review and Meta-Analysis. JAMA Intern Med. 2024 May 01; 184(5):474-482. PMID: 38436976.

Published on 5/1/2024

Law AC, Bosch NA, Song Y, Tale A, Lasser KE, Walkey AJ. In-Hospital vs 30-Day Sepsis Mortality at US Safety-Net and Non-Safety-Net Hospitals. JAMA Netw Open. 2024 May 01; 7(5):e2412873. PMID: 38819826.

Published on 4/9/2024

Myers LC, Peltan ID, Thai KK, Kipnis P, Desai M, Devis Y, Clancy H, Lu YW, Brown SM, Go AS, Neugebauer RS, Liu VX, Walkey AJ. Predicting stroke risk after sepsis hospitalization with new-onset atrial fibrillation. J Hosp Med. 2024 Jul; 19(7):565-571. PMID: 38594918.

Published on 4/5/2024

Andriola C, Ellis RP, Siracuse JJ, Hoagland A, Kuo TC, Hsu HE, Walkey A, Lasser KE, Ash AS. A Novel Machine Learning Algorithm for Creating Risk-Adjusted Payment Formulas. JAMA Health Forum. 2024 Apr 05; 5(4):e240625. PMID: 38639980.

View full list of 299 publications.